These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052 [TBL] [Abstract][Full Text] [Related]
7. Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide. Yahi N; Fantini J PLoS One; 2014; 9(8):e104751. PubMed ID: 25140899 [TBL] [Abstract][Full Text] [Related]
8. Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein. Ulamec SM; Maya-Martinez R; Byrd EJ; Dewison KM; Xu Y; Willis LF; Sobott F; Heath GR; van Oosten Hawle P; Buchman VL; Radford SE; Brockwell DJ Nat Commun; 2022 Aug; 13(1):4986. PubMed ID: 36008493 [TBL] [Abstract][Full Text] [Related]
9. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau. Bhasne K; Sebastian S; Jain N; Mukhopadhyay S J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492 [TBL] [Abstract][Full Text] [Related]
10. The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. Fantini J; Yahi N Adv Exp Med Biol; 2013; 991():15-26. PubMed ID: 23775688 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates. Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease. Werner T; Horvath I; Wittung-Stafshede P J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869 [TBL] [Abstract][Full Text] [Related]
13. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease. Galvagnion C J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142 [TBL] [Abstract][Full Text] [Related]
14. Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. Hellstrand E; Grey M; Ainalem ML; Ankner J; Forsyth VT; Fragneto G; Haertlein M; Dauvergne MT; Nilsson H; Brundin P; Linse S; Nylander T; Sparr E ACS Chem Neurosci; 2013 Oct; 4(10):1339-51. PubMed ID: 23823878 [TBL] [Abstract][Full Text] [Related]
15. Interplay between α-synuclein amyloid formation and membrane structure. O'Leary EI; Lee JC Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):483-491. PubMed ID: 30287222 [TBL] [Abstract][Full Text] [Related]